Abstract
New risk factors associated with relapse of stage I testicular cancer have been identified. These new factors reflect the risk of recurrence much better than previous parameters and can be used to assess the possible effect of adjuvant chemotherapy.
Original language | English |
---|---|
Journal | European Urology Focus |
Volume | 10 |
Issue number | 3 |
Pages (from-to) | 359-360 |
Number of pages | 2 |
ISSN | 2405-4569 |
DOIs | |
Publication status | Published - May 2024 |
Keywords
- Chemotherapy, Adjuvant
- Humans
- Male
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasms, Germ Cell and Embryonal/pathology
- Risk Factors
- Seminoma/pathology
- Testicular Neoplasms/pathology
- Watchful Waiting